DiaMedica Therapeutics Inc.
DMAC
$3.53
-$0.01-0.28%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -53.07% | -40.33% | -14.34% | 2.30% | -37.59% |
| Total Depreciation and Amortization | 37.50% | 25.00% | 42.86% | 14.29% | 33.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 159.81% | 1,052.63% | -15.88% | -24.36% | -64.21% |
| Change in Net Operating Assets | -4.62% | 546.18% | 161.23% | -2,808.62% | 81.47% |
| Cash from Operations | -68.78% | 6.82% | 10.16% | -30.73% | -37.82% |
| Capital Expenditure | -133.33% | 10.00% | 100.00% | -28.57% | 90.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.93% | -562.35% | 116.84% | 67.61% | 28.83% |
| Cash from Investing | -15.01% | -566.97% | 116.84% | 67.72% | 29.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -200.00% | -50.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -- | -68.10% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12,100.00% | 2,150.00% | -68.11% | 0.00% | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -147.99% | -175.35% | 224.19% | 5.23% | 18.09% |